In the News
Sarasota researchers host memory screening for Alzheimer’s
By Sydney RoellSARASOTA COUNTY, Fla. (SNN) — In honor of Sept. 21 being World Alzheimer’s Day, a group of Sarasota researchers hosted a free bilingual memory screening. Intercoastal Medical Group Neurology and Research Clinic offered their free, confidential memory screening in English and Spanish on Thursday from 8 a.m. to 3 p.m. at Robert L. Taylor […]
A healthy diet may lower dementia risk — even if you start late
By Janet Lee – Washington Post Consumer Reports has no financial relationship with any advertisers on this site. Doing puzzles, playing memory-boosting games, taking classes and reading are activities that we often turn to for help keeping our brains sharp. But research is showing that what you eat, how often you exercise and the type of exercise you do […]
Sarasota researchers plan free, bilingual memory screening on World Alzheimer’s Day
Free, bilingual screening on World Alzheimer’s Day Intercoastal Medical Group Neurology and Research Clinic will hold a free, bilingual?memory?screening event on World Alzheimer’s Day on Sept. 21 from 8 a.m. to 3 p.m. at Robert L. Taylor Community Complex, 1845 John Rivers St., in Sarasota. The goal of the confidential? screening in English and Spanish […]
Aumentan los casos de Alzheimer en el Valle de Texas
Jessica Cantu from GAP-Net site El Faro Health and Therapeutics was at the Alzheimer’s Association’s International Conference (AAIC) in Amsterdam and spoke about the creation of the site in Starr County, Texas. En el condado Starr, casi uno en cada cuatro adultos de 65 años de edad en adelante fueron diagnosticados con Alzheimer en el […]
Next On Medicare’s To Do List For Alzheimer’s: Coverage Of PET Scans And Genetic Testing
By Cathy Kelly Medicare policymakers have felt that without an effective approved treatment, coverage of amyloid PET scans and APOE4 genetic tests was not warranted. But that is changing. There is more to Medicare coverage for Alzheimer’s treatment than Leqembi, Eisai Co., Ltd. and Biogen, Inc.’s newly-approved amyloid-targeting monoclonal antibody. Now the program also is considering amending restrictive coverage […]
Broader Medicare Coverage For Leqembi Begins As CMS-Backed Registry Opens For Business
By Cathy Kelly There is no fee to participate, and entries to the registry must be made at baseline and then every six months for up to two years. The Centers for Medicare and Medicaid Services is sticking with its plan to provide broader Medicare coverage for Eisai Co., Ltd. and Biogen, Inc.’s Leqembi for Alzheimer’s – now that […]
The Numbers Tell The Story: Alzheimer’s Disproportionate Impact On Black Americans
GAP Community Connector, Paula Atkinson, was a guest writer for the Orlando Times and explained why she and GAP are committed to advancing Alzheimer’s clinical research in Black and Brown communities. My grandmother was treated for Alzheimer’s disease, but never diagnosed with it. Why? She was toldby her doctor that it would take too long […]
Kerwin Medical Center seeks to slow the progression of Alzheimer’s disease
GAP-Net Site Kerwin Medical Center was featured in Community Impact on the rate of Alzheimer’s disease in Hispanic communities, and how they can help. As part of a nationwide study, Kerwin Medical Center is testing the efficacy of Aducanumab, a drug that helps a type of plaque in the brain and slows memory impairment caused […]
New research Study Examines Potential Alzheimer’s Treatment To Help Address “Silent Epidemic” In The Orlando Black Community
GAP-Net Site K2 Medical Research was featured in the Orlando Times speaking about the rate of Alzheimer’s in the black community, and studies they have that can help. ORLANDO – For the 580,000 Floridians who are living with Alzheimer’s disease, or for the state’s 1.1 million citizens who who serve as unpaid Alzheimer’s caregivers, one […]
Drugmaker Warns US Data Rules Threaten Access to Alzheimer’s Treatment
GAP President John Dwyer was quoted in the Financial Times talking about how the CMS decision will limit patient access to possible life saving Alzheimer’s treatments. Eisai has warned that mandatory data collection by US health authorities could restrictpatient access to the Japanese drugmaker’s new Alzheimer’s treatment. The company said a decision by Centers for […]